Page last updated: 2024-10-15

2,3-diphosphoglycerate and Cardiomyopathies

2,3-diphosphoglycerate has been researched along with Cardiomyopathies in 1 studies

2,3-Diphosphoglycerate: A highly anionic organic phosphate which is present in human red blood cells at about the same molar ratio as hemoglobin. It binds to deoxyhemoglobin but not the oxygenated form, therefore diminishing the oxygen affinity of hemoglobin. This is essential in enabling hemoglobin to unload oxygen in tissue capillaries. It is also an intermediate in the conversion of 3-phosphoglycerate to 2-phosphoglycerate by phosphoglycerate mutase (EC 5.4.2.1). (From Stryer Biochemistry, 4th ed, p160; Enzyme Nomenclature, 1992, p508)
2,3-bisphosphoglyceric acid : A bisphosphoglyceric acid that is glyceric acid carrying two phospho substituents at positions 2 and 3.

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ariyoshi, N1
Nogi, M1
Ando, A1
Watanabe, H1
Umekawa, S1

Reviews

1 review available for 2,3-diphosphoglycerate and Cardiomyopathies

ArticleYear
Hypophosphatemia-induced Cardiomyopathy.
    The American journal of the medical sciences, 2016, Volume: 352, Issue:3

    Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Animals; Cardiomyopathies; Heart; Heart Function Tes

2016